International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 3 , Pages 741-746 , 1 March 2010

Focal Salvage Guided by T2-Weighted and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prostate Cancer Recurrences

Presented, in part, in abstract form as a poster presentation at the 27th meeting of the European Society for Therapeutic Radiology and Oncology, September 14–18, 2008, Göteborg, Sweden.

  • Maaike R. Moman, M.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • Corresponding Author InformationReprint requests to: Maaike R. Moman, M.D., Department of Radiation Oncology, 000.118, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX The Netherlands. Tel: (+31) 88-755-7208; Fax: (+31) 88-755-5850
    • ,
  • Cornelis A.T. van den Berg, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Arto E. Boeken Kruger, M.D.

      Affiliations

    • Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Jan J. Battermann, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Marinus A. Moerland, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Uulke A. van der Heide, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Marco van Vulpen, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Received 2 October 2008 ,Revised 27 January 2009 ,Accepted 14 February 2009.

References 

  1. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097–1105
  2. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA. 2005;294:1233–1239
  3. Al Mamgani A, van Putten WL, Heemsbergen WD, et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:980–988
  4. Nguyen PL, D'Amico AV, Lee AK, et al. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer. 2007;110:1417–1428
  5. Beyer DC. Salvage brachytherapy after external-beam irradiation for prostate cancer. Oncology (Williston Park). 2004;18:151–158
  6. Pucar D, Hricak H, Shukla-Dave A, et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: Magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys. 2007;69:62–69
  7. Cellini N, Morganti AG, Mattiucci GC, et al. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: Implications for conformal therapy planning. Int J Radiat Oncol Biol Phys. 2002;53:595–599
  8. Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology. 2006;241:449–458
  9. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging. 2004;20:654–661
  10. Van Dorsten FA, van der Graaf M, Engelbrecht MR, et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging. 2004;20:279–287
  11. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: Correlation with morphology and tumor stage, histological grade and PSA. Clin Radiol. 2000;55:99–109
  12. Kershaw LE, Logue JP, Hutchinson CE, et al. Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging. Radiother Oncol. 2008;88:127–134
  13. Haider MA, Chung P, Sweet J, et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:425–430
  14. Rouviere O, Valette O, Grivolat S, et al. Recurrent prostate cancer after external beam radiotherapy: Value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor—Correlation with biopsy findings. Urology. 2004;63:922–927
  15. Battermann JJ. I-125 implantation for localized prostate cancer: The Utrecht University experience. Radiother Oncol. 2000;57:269–272
  16. Nederveen AJ, van der Heide UA, Hofman P, et al. Partial boosting of prostate tumors. Radiother Oncol. 2001;61:117–126
  17. Buyyounouski MK, Hanlon AL, Eisenberg DF, et al. Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. Int J Radiat Oncol Biol Phys. 2005;63:1455–1462
  18. Heidenreich A, Aus G, Bolla M, et al. EAU guidelines on prostate cancer. Eur Urol. 2008;53:68–80
  19. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–232
  20. Lessard E, Pouliot J. Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function. Med Phys. 2001;28:773–779
  21. Kovacs G, Potter R, Loch T, et al. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol. 2005;74:137–148
  22. Pucar D, Sella T, Schoder H. The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. Curr Opin Urol. 2008;18:87–97
  23. Kaplan I, Oldenburg NE, Meskell P, et al. Real time MRI-ultrasound image guided stereotactic prostate biopsy. Magn Reson Imaging. 2002;20:295–299
  24. Singh AK, Kruecker J, Xu S, et al. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int. 2008;101:841–845
  25. Eggener SE, Scardino PT, Carroll PR, et al. Focal therapy for localized prostate cancer: A critical appraisal of rationale and modalities. J Urol. 2007;178:2260–2267
  26. Padhani AR, MacVicar AD, Gapinski CJ, et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology. 2001;218:365–374
  27. Menard C, Smith IC, Somorjai RL, et al. Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: A histopathologic study of diagnostic validity. Int J Radiat Oncol Biol Phys. 2001;50:317–323
  28. Kurhanewicz J, Vigneron DB, Hricak H, et al. Prostate cancer: Metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology. 1996;200:489–496
  29. Coakley FV, Teh HS, Qayyum A, et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: Preliminary experience. Radiology. 2004;233:441–448
  30. Eisenberg ML, Shinohara K. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology. 2008;72:1315–1318
  31. Ahmed HU, Pendse D, Illing R, et al. Will focal therapy become a standard of care for men with localized prostate cancer?. Nat Clin Pract Oncol. 2007;4:632–642
  32. Bahn DK, Silverman P, Lee F, et al. Focal prostate cryoablation: Initial results show cancer control and potency preservation. J Endourol. 2006;20:688–692
  33. Onik G. Rationale for a “male lumpectomy,” a prostate cancer targeted approach using cryoablation: Results in 21 patients with at least 2 years of follow-up. Cardiovasc Intervent Radiol. 2008;31:98–106

 Supported by a grant from the Dutch Cancer Society.

 Conflict of interest: none.

PII: S0360-3016(09)00352-6

doi: 10.1016/j.ijrobp.2009.02.055

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 3 , Pages 741-746 , 1 March 2010

Article Tools

* Image Usage & Resolution